Cargando…

Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

BACKGROUND: The benefits and risks of antiplatelet therapy for patients with chronic kidney disease (CKD) remain controversial. We undertook a systematic review and meta-analysis to investigate the effects of antiplatelet therapy on major clinical outcomes. METHODS: We systematically searched MEDLIN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Xiaole, Yan, Bingjuan, Wang, Lihua, Lv, Jicheng, Cheng, Hong, Chen, Yipu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686545/ https://www.ncbi.nlm.nih.gov/pubmed/31390997 http://dx.doi.org/10.1186/s12882-019-1499-3

Ejemplares similares

Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis
por: Shi, Honghong, et al.
Publicado: (2022)

Comparative efficacy and safety of oral anticoagulants for the treatment of venous thromboembolism in the patients with different renal functions: a systematic review, pairwise and network meta-analysis
por: Su, Xiaole, et al.
Publicado: (2022)

Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis
por: Su, Xiaole, et al.
Publicado: (2017)

Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis
por: Yan, Bingjuan, et al.
Publicado: (2018)

Cardiovascular and kidney outcomes of uric acid-lowering therapy in patients with different kidney functions: study protocol for a systematic review, pairwise and network meta-analysis
por: Zhang, Yaqing, et al.
Publicado: (2023)

Effect of a low-salt diet on chronic kidney disease outcomes: a systematic review and meta-analysis
por: Shi, Honghong, et al.
Publicado: (2022)

Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
por: Kao, Chih-Chin, et al.
Publicado: (2021)

Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation?
por: Alonso-Escalante, Jose C., et al.
Publicado: (2021)

The pregnancy outcomes in patients with stage 3–4 chronic kidney disease and the effects of pregnancy in the long-term kidney function
por: He, Yingdong, et al.
Publicado: (2018)

Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease
por: Rymer, Jennifer A., et al.
Publicado: (2019)

Effect of clinical decision support systems on clinical outcome for acute kidney injury: a systematic review and meta-analysis
por: Zhao, Youlu, et al.
Publicado: (2021)

Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis
por: Major, Rupert W., et al.
Publicado: (2018)

Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
por: Hong, Bum-Kee
Publicado: (2010)

P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
por: Park, Sohyun, et al.
Publicado: (2021)

Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
por: Edmonston, Daniel, et al.
Publicado: (2023)

Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial
por: Xiong, Jiachuan, et al.
Publicado: (2021)

Novel aspects of antiplatelet therapy in cardiovascular disease
por: Gremmel, Thomas, et al.
Publicado: (2018)

The Association of Losartan and Ramipril Therapy With Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: A Chinese Nation-Wide Cohort Study in Taiwan
por: Hsing, Shih-Chun, et al.
Publicado: (2015)

Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis
por: Tang, Chen, et al.
Publicado: (2023)

Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease
por: Cejka, Daniel
Publicado: (2021)

The Effect of Statin on Anemia in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis
por: Tsai, Meng-Hsu, et al.
Publicado: (2022)

Glomerular C4d Deposition and Kidney Disease Progression in IgA Nephropathy: A Systematic Review and Meta-analysis
por: Jiang, Yuanyuan, et al.
Publicado: (2021)

Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
por: Kanji, Tahir, et al.
Publicado: (2015)

Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis
por: Shah, Sahrish, et al.
Publicado: (2022)

A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes
por: Hultin, Sebastian, et al.
Publicado: (2020)

Dual Antiplatelet Therapy vs. Single Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: An Updated Systematic Review and Meta-Analysis
por: Zhang, Yipeng, et al.
Publicado: (2021)

Balancing Antiplatelet and Anticoagulant Therapies in Patients with Cardiovascular Disease
por: Carreras, Edward T., et al.
Publicado: (2013)

Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases
por: Jourdi, Georges, et al.
Publicado: (2021)

Relationship between sex and cardiovascular mortality in chronic kidney disease: A systematic review and meta-analysis
por: Shajahan, Sultana, et al.
Publicado: (2021)

Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis
por: Zhou, Le-Ting, et al.
Publicado: (2016)

The effect of hormone therapy on all-cause and cardiovascular mortality in women with chronic kidney disease: protocol for a systematic review and meta-analysis
por: Ramesh, Sharanya, et al.
Publicado: (2015)

Kidney function, cardiovascular outcomes and survival of living kidney donors with hypertension: a systematic review protocol
por: Bugeja, Ann, et al.
Publicado: (2022)

Prophylactic Add-on Antiplatelet Therapy in Chronic Kidney Disease With Type 2 Diabetes Mellitus: Comparison Between Clopidogrel and Low-dose Aspirin
por: Dash, Amitabh, et al.
Publicado: (2013)

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
por: Agarwal, Rajiv, et al.
Publicado: (2021)

Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis
por: Sharma, Gaurav, et al.
Publicado: (2021)

Thyroid dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic review and meta-analysis
por: Liu, Tongtong, et al.
Publicado: (2020)

Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease
por: Jhee, Jong Hyun, et al.
Publicado: (2020)

The role of serum testosterone and dehydroepiandrosterone sulfate in kidney function and clinical outcomes in chronic kidney disease: a systematic review and meta-analysis
por: van der Burgh, Anna C, et al.
Publicado: (2022)

Effects of contralateral nephrectomy timing and ischemic conditions on kidney fibrosis after unilateral kidney ischemia-reperfusion injury
por: Zhang, Junhua, et al.
Publicado: (2022)

Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease
por: Tsai, Yi-Chun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1t1k648mcirkvl8nsvo8sc2sga